source
- Pfizer expands cost-cutting program, targeting $1 billion in new savings through 2029Pfizer announced it is expanding a cost-cutting initiative first launched in 2023 to further reduce expenses. The new measures are projected to generate about $1 billion in additional savings by 2…
- Eli Lilly expands early-access program for experimental obesity drug retatrutideEli Lilly announced it will broaden its early-access initiative for retatrutide, an investigational drug targeting obesity. The company said the program will let additional patients apply for the…